IDEAS home Printed from https://ideas.repec.org/p/fda/fdafen/2022-03.html
   My bibliography  Save this paper

Comentario al proyecto de ley de creación y crecimiento de empresas

Author

Listed:
  • Benito Arruñada

Abstract

Las empresas españolas sufren todo tipo de dificultades como consecuencia de un ordenamiento fiscal y regulatorio que numerosos informes internacionales consideran notoriamente mejorable. Por este motivo, son bienvenidos los esfuerzos para reformarlo y aliviar as las cargas y frenos a la creación y desarrollo de la empresa. En este sentido, es positivo que el Gobierno se haya comprometido con la Comisión Europea a efectuar una reforma estructural en esta materia, un compromiso al que intenta dar cumplimiento con el proyecto de ley de creación y crecimiento de empresas, la conocida como “Ley Crea y Crece”, la cual “tiene por objeto mejorar el clima de negocios, impulsar el emprendimiento y fomentar el aumento del tama o empresarial, así como el despliegue de redes de colaboración e interacción".

Suggested Citation

  • Benito Arruñada, 2022. "Comentario al proyecto de ley de creación y crecimiento de empresas," Fedea Economy Notes 2022-03, FEDEA.
    • Handle: RePEc:fda:fdafen:2022-03
    as

    Download full text from publisher

    File URL: https://documentos.fedea.net/pubs/ap/2022/ap2022-03.pdf
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Angel de la Fuente, 2023. "Seguimiento de las reformas e inversiones del Plan de Recuperación. Boletín FEDEA no. 20," Studies on the Spanish Economy eee2023-02, FEDEA.

    More about this item

    NEP fields

    This paper has been announced in the following NEP Reports:

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:fda:fdafen:2022-03. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Carmen Arias (email available below). General contact details of provider: https://www.fedea.net .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.